Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study [PDF]
, 2018 Purpose. To evaluate the efficacy and safety of a single intravitreal dexamethasone implant (DXI) combined with intravitreal antivascular endothelial growth factor (anti-VEGF) therapy, in patients with neovascular age-related macular degeneration (wet ...
Boscia, Francesco +6 more
core +2 more sources
Collagen cross-linking in the treatment of pellucid marginal degeneration
Indian Journal of Ophthalmology, 2014 Pellucid marginal degeneration (PMD) is an uncommon cause of inferior peripheral corneal thinning disorder, characterized by irregular astigmatism. We analyzed a case of bilateral PMD patient and treated one eye with corneal collagen cross-linking (CXL ...
Ziad Hassan +4 more
doaj +1 more source
Indian Journal of Ophthalmology, 2014 Background: Regular follow up and amblyopia treatment are essential for good outcomes after pediatric cataract surgery. Aim: To study the regularity of follow-up after cataract surgery in children and to gauge the causes of poor compliance to follow up ...
Parikshit Gogate +7 more
doaj +1 more source
Emerging Pharmacotherapies for Diabetic Macular Edema [PDF]
, 2012 Diabetic macular edema (DME) remains an important cause of visual loss in patients with diabetes mellitus. Although photocoagulation and intensive control of systemic metabolic factors have been reported to achieve improved outcomes in large randomized ...
Golnaz Javey +2 more
core +2 more sources
Anti-vascular endothelial growth factor for diabetic macular oedema. [PDF]
, 2014 BACKGROUND: Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk of visual loss in DMO, or clinically significant macular oedema (CSMO), vision is ...
Evans, Jennifer R +3 more
core +1 more source
Preliminary Assessment of Celecoxib and Microdiode Pulse Laser Treatment of Diabetic Macular Edema [PDF]
, 2018 Purpose: Inflammation may play an important role in the pathogenesis of diabetic macular edema, a major cause of vision loss in persons with diabetes. The purpose of this study was to evaluate combined antiinflammatory therapy and laser approaches for ...
Aiello, Lloyd Paul +13 more
core +1 more source
Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10 [PDF]
, 2011 To investigate baseline factors significantly associated with visual acuity and central retinal thickness outcomes in patients with macular edema secondary to retinal vein occlusion in the Standard Care versus COrticosteroid for REtinal Vein Occlusion ...
Blodi, Barbara A. +6 more
core +2 more sources
A Clinical study on Cystoid Macular Edema due to Vein Occlusion and Its Management [PDF]
, 2017 AIM OF THE STUDY: To compare the functional , anatomical and therapeutic outcome of patients with cystoid macular oedema due to retinal vein occlusion.
Shalini, S
core
The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol [PDF]
, 2016 BackgroundMacular oedema (MO) describes the accumulation of fluid in the central part of the retina, known as the ‘macula’ which provides central vision. MO is the leading cause of sight loss in patients with intraocular inflammation (uveitis).
Bucknall, Nick +5 more
core +2 more sources
Clinical preferences and trends of anti‐vascular endothelial growth factor treatments for diabetic macular edema in Japan [PDF]
, 2018 Aims/Introduction: To determine the current clinical preferences of anti‐vascular endothelial growth factor (VEGF) treatment protocols for diabetic macular edema (DME) in Japan. Materials and Methods: This was a descriptive cross‐sectional study. Answers
207501/profile-ja.html +62 more
core